Poster embargo24 Apr 2025 11:49
Likely Reasons for Embargo
🔬 1. High-Impact or Novel Therapeutic Insight
Targeting FAPα for drug delivery in cancer therapy is a hot and emerging area.
If this presentation contains new findings on spatial localization or functional roles of FAPα, it's probably considered high-impact, which warrants coordination with a journal publication or media release.
💊 2. Involves a Proprietary Platform (pre|CISION®)
The use of the pre|CISION® platform indicates a commercial or IP-protected technology, likely from a biotech company.
Embargoes are common when intellectual property or strategic partnerships (e.g., pharma collaborations or funding rounds) are in play.
📰 3. Press and Media Coordination
Abstracts like this often come from big cancer meetings (like AACR, ASCO, etc.) where the organizers embargo abstracts until a certain date/time to coordinate press coverage.
This ensures journalists don’t scoop the story prematurely and that scientific accuracy is maintained.
📄 4. Concurrent Peer-Reviewed Publication
It’s possible the results are being published in a journal simultaneously with the conference.
Journals often impose embargoes until publication goes live, even on conference abstracts.